The FDA has scheduled an Oct. 15 meeting of its advisory committee to discuss whether to grant authorization for a booster dose of the J&J vaccine.
Related Articles
-
Child and teen cancer deaths fell 24% in the last 2 decades, CDC says
The rate of child and teen cancer deaths in the United States fell 24% between 2001 and 2021, according...
-
Illnesses linked to McDonald’s E. coli outbreak rise to 75, CDC says
At least 75 people have gotten sick after eating McDonald’s Quarter Pounders linked to a deadly E. coli strain,...
-
‘This will shut us down’: HIV prevention clinics brace for Gilead reimbursement cuts
Tony Christon-Walker was determined to set up an HIV prevention clinic in Birmingham, Alabama, that would succeed where others...
-
Alpha-gal syndrome has afflicted thousands, CDC says 42% of doctors have never heard of it
IE 11 is not supported. For an optimal experience visit our site on another browser. Now Playing Alpha-gal syndrome...
-
Israel launches Covid-19 vaccination pass
JERUSALEM — Israel reopened swathes of its economy including malls and leisure facilities on Sunday, with the government saying...
-
FDA panel recommends updating Covid boosters for the fall
Advisers to the Food and Drug Administration on Thursday recommended updating the Covid vaccines to target a circulating strain...
-
Anthony Fauci to step down in December as Biden’s lead medical adviser
Dr. Anthony Fauci will leave his positions as director of NIAID and chief medical advisor to President Biden in...
-
Florida to allow doctors to perform C-sections outside hospitals
Florida has become the first state to allow doctors to perform cesarean sections outside of hospitals, siding with a...
Recent Comments